U-Blot® Research Grade TregalizumabCat. No. WA3700Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TregalizumabCat. No. WA3700U-Blot® Research Grade TrebananibCat. No. WA3699Request quote
Size: 50ug/100ug
U-Blot® Research Grade TraxivitugCat. No. WA3698Request quote
Size: 50ug/100ug
U-Blot® Research Grade TrastuzumabCat. No. WA3697Request quote
Size: 50ug/100ug
U-Blot® Research Grade TralokinumabCat. No. WA3696Request quote
Size: 50ug/100ug
U-Blot® Research Grade TrabikibartCat. No. WA3695Request quote
Size: 50ug/100ug
U-Blot® Research Grade TozorakimabCat. No. WA3694Request quote
Size: 50ug/100ug
U-Blot® Research Grade TovetumabCat. No. WA3693Request quote
Size: 50ug/100ug
U-Blot® Research Grade tovecimigCat. No. WA3692Request quote
Size: 50ug/100ug
U-Blot® Research Grade TositumomabCat. No. WA3691Request quote
Size: 50ug/100ug
U-Blot® Research Grade TosatoxumabCat. No. WA3690Request quote
Size: 50ug/100ug
U-Blot® Research Grade torvutatugCat. No. WA3689Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598